SOURCE: PHT Corporation

October 16, 2007 09:00 ET

PHT and Sucampo to Speak About eClinical Data Integration at CBI's Premier Conference on PRO

BOSTON, MA--(Marketwire - October 16, 2007) - PHT Corporation and Sucampo Pharmaceuticals (NASDAQ: SCMP) today announced that they will present a featured session on eClinical data integration at the inaugural Center for Business Intelligence (CBI) Conference on Patient Reported Outcomes. PHT, the leading provider of electronic patient reported outcome (ePRO) solutions used in more than 300 clinical trials worldwide, is co-sponsoring the conference.

CBI ( is a world-class conference company that produces high-level programs for executive decision-makers, and annually hosts several of the pharmaceutical industry's most productive meetings.

The PRO conference, to be held in Washington, D.C., on November 28-29, features an agenda designed to help participants integrate and validate ePRO tools to improve patient safety, achieve commercial objectives, and ensure FDA acceptance of outcomes data.

PHT and Sucampo's session (November 29, 9:45 am) details a case study of integrating eDiary data into a leading EDC system to consolidate key clinical data for review by sites and CRAs. The presentation will conclude with an innovative discussion regarding additional options for data integration, such as clinical data management systems, automatic eligibility calculations, and other PRO measurement devices.

PHT will also exhibit hands-on demonstrations of groundbreaking ePRO products, such as the exclusive SimpleSend™ Wireless Pak and a preview of the StudyPad® tablet, at the conference.

Phil Lee, PHT President and CEO, said, "PHT is pleased to co-sponsor CBI's conference. The meeting will offer valuable information and resources to support companies' adoption of ePRO technology."

For more information on the CBI Conference contact Jamie McHugh at 781-939-2406 or

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 300 clinical trials around the world. The company's proven LogPad® and StudyPad® Systems deliver the voice of the patient -- directly and without distortion -- with reliable and timely self-reported data. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least eight NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit

PHT, LogPad and StudyPad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information

  • For more information on PHT call
    Brenda Nashawaty
    Email Contact